Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate

PURPOSE: To evaluate the outcomes of ruthenium-106 ((106)Ru) brachytherapy in terms of radiation parameters in patients with thick uveal melanomas. MATERIAL AND METHODS: Medical records of 51 patients with thick (thickness ≥ 7 mm and < 11 mm) uveal melanoma treated with (106)Ru brachytherapy duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Naseripour, Masood, Jaberi, Ramin, Sedaghat, Ahad, Azma, Zohreh, Nojomi, Marzieh, Falavarjani, Khalil Ghasemi, Nazari, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793070/
https://www.ncbi.nlm.nih.gov/pubmed/26985199
http://dx.doi.org/10.5114/jcb.2016.57818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793070/
https://www.ncbi.nlm.nih.gov/pubmed/26985199
http://dx.doi.org/10.5114/jcb.2016.57818

Ejemplares similares